Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
A very good place to experience a lot and move at a fast pace; however, often frustrating due to lack of focus on main objectives for the company.
Qual è la parte migliore del tuo compenso?
It is competitive with industry standards
Cosa ti piace di più del team di leadership?
Open minded to alternative approaches and collaborative across functions
Quali sono alcune delle cose migliori della tuo team?
Very collaborative and talented group
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
Coworkers are friendly and talented
Che cosa sta andando male e come può essere migliorato?
Inconsistent goals and constantly shifting priorities by the day. Management rushes too much to push multiple objectives forward which results in work that often must be repeated or adjusted. More focus is needed to focus on a clear set of objectives.
Other Employee Reviews for Karyopharm Therapeutics
×